Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1483064rdf:typepubmed:Citationlld:pubmed
pubmed-article:1483064lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:1483064lifeskim:mentionsumls-concept:C1556094lld:lifeskim
pubmed-article:1483064lifeskim:mentionsumls-concept:C0008312lld:lifeskim
pubmed-article:1483064lifeskim:mentionsumls-concept:C0521451lld:lifeskim
pubmed-article:1483064lifeskim:mentionsumls-concept:C0004359lld:lifeskim
pubmed-article:1483064lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:1483064lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:1483064pubmed:issue1lld:pubmed
pubmed-article:1483064pubmed:dateCreated1993-2-17lld:pubmed
pubmed-article:1483064pubmed:abstractTextPrimary biliary cirrhosis (PBC) has been described among various ethnic and racial populations in all parts of the world. However, the incidence and prevalence of PBC varies considerably in different geographic areas. It has the highest frequency in Northern Europe, is considerably lower in Japan and still lower in other parts of Asia. There has not hitherto been a detailed immunological profile of antimitochondrial antibodies according to geographic region. We have used recombinant or purified preparations from the 2-oxo-acid dehydrogenase enzyme complexes, the major mitochondrial autoantigens in PBC (PDC-E2, BCOADC-E2, OGDC, protein X and PDC-E1 alpha) to compare the reactivity of sera from either similarly staged sera from Japanese (n = 23) or American-Caucasian patients (n = 39) with PBC. In all cases, the first available sera following diagnosis was selected. Interestingly, only 65% of Japanese patients reacted by ELISA with PDC-E2 compared with more than 95% of the North American group. Moreover, the level of enzyme-inhibitory antibodies to PDC was lower in the Japanese. Our findings prompt the need for characterization of specific susceptibility genes and environmental factors in various parts of the world to clarify the etiology of PBC.lld:pubmed
pubmed-article:1483064pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1483064pubmed:languageenglld:pubmed
pubmed-article:1483064pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1483064pubmed:citationSubsetIMlld:pubmed
pubmed-article:1483064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1483064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1483064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1483064pubmed:statusMEDLINElld:pubmed
pubmed-article:1483064pubmed:issn1018-2438lld:pubmed
pubmed-article:1483064pubmed:authorpubmed-author:GershwinM EMElld:pubmed
pubmed-article:1483064pubmed:authorpubmed-author:NakagawaTTlld:pubmed
pubmed-article:1483064pubmed:authorpubmed-author:MackayI RIRlld:pubmed
pubmed-article:1483064pubmed:authorpubmed-author:DicksonE RERlld:pubmed
pubmed-article:1483064pubmed:authorpubmed-author:NishiokaMMlld:pubmed
pubmed-article:1483064pubmed:authorpubmed-author:CoppelR LRLlld:pubmed
pubmed-article:1483064pubmed:authorpubmed-author:LeungP SPSlld:pubmed
pubmed-article:1483064pubmed:authorpubmed-author:MunozSSlld:pubmed
pubmed-article:1483064pubmed:authorpubmed-author:RowleyMMlld:pubmed
pubmed-article:1483064pubmed:authorpubmed-author:IwayamaTTlld:pubmed
pubmed-article:1483064pubmed:issnTypePrintlld:pubmed
pubmed-article:1483064pubmed:volume99lld:pubmed
pubmed-article:1483064pubmed:ownerNLMlld:pubmed
pubmed-article:1483064pubmed:authorsCompleteYlld:pubmed
pubmed-article:1483064pubmed:pagination28-33lld:pubmed
pubmed-article:1483064pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1483064pubmed:meshHeadingpubmed-meshheading:1483064-...lld:pubmed
pubmed-article:1483064pubmed:meshHeadingpubmed-meshheading:1483064-...lld:pubmed
pubmed-article:1483064pubmed:meshHeadingpubmed-meshheading:1483064-...lld:pubmed
pubmed-article:1483064pubmed:meshHeadingpubmed-meshheading:1483064-...lld:pubmed
pubmed-article:1483064pubmed:meshHeadingpubmed-meshheading:1483064-...lld:pubmed
pubmed-article:1483064pubmed:meshHeadingpubmed-meshheading:1483064-...lld:pubmed
pubmed-article:1483064pubmed:meshHeadingpubmed-meshheading:1483064-...lld:pubmed
pubmed-article:1483064pubmed:meshHeadingpubmed-meshheading:1483064-...lld:pubmed
pubmed-article:1483064pubmed:meshHeadingpubmed-meshheading:1483064-...lld:pubmed
pubmed-article:1483064pubmed:meshHeadingpubmed-meshheading:1483064-...lld:pubmed
pubmed-article:1483064pubmed:meshHeadingpubmed-meshheading:1483064-...lld:pubmed
pubmed-article:1483064pubmed:meshHeadingpubmed-meshheading:1483064-...lld:pubmed
pubmed-article:1483064pubmed:meshHeadingpubmed-meshheading:1483064-...lld:pubmed
pubmed-article:1483064pubmed:meshHeadingpubmed-meshheading:1483064-...lld:pubmed
pubmed-article:1483064pubmed:meshHeadingpubmed-meshheading:1483064-...lld:pubmed
pubmed-article:1483064pubmed:year1992lld:pubmed
pubmed-article:1483064pubmed:articleTitleComparative immunoreactive profiles of Japanese and American patients with primary biliary cirrhosis against mitochondrial autoantigens.lld:pubmed
pubmed-article:1483064pubmed:affiliationFirst Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.lld:pubmed
pubmed-article:1483064pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1483064pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1483064pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed